» Articles » PMID: 33937868

Biomechanical Regulation of Hematopoietic Stem Cells in the Developing Embryo

Overview
Specialty Cell Biology
Date 2021 May 3
PMID 33937868
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: The contribution of biomechanical forces to hematopoietic stem cell (HSC) development in the embryo is a relatively nascent area of research. Herein, we address the biomechanics of the endothelial-to-hematopoietic transition (EHT), impact of force on organelles, and signaling triggered by extrinsic forces within the aorta-gonad-mesonephros (AGM), the primary site of HSC emergence.

Recent Findings: Hemogenic endothelial cells undergo carefully orchestrated morphological adaptations during EHT. Moreover, expansion of the stem cell pool during embryogenesis requires HSC extravasation into the circulatory system and transit to the fetal liver, which is regulated by forces generated by blood flow. Findings from other cell types also suggest that forces external to the cell are sensed by the nucleus and mitochondria. Interactions between these organelles and the actin cytoskeleton dictate processes such as cell polarization, extrusion, division, survival, and differentiation.

Summary: Despite challenges of measuring and modeling biophysical cues in the embryonic HSC niche, the past decade has revealed critical roles for mechanotransduction in governing HSC fate decisions. Lessons learned from the study of the embryonic hematopoietic niche promise to provide critical insights that could be leveraged for improvement in HSC generation and expansion ex vivo.

Citing Articles

Pumping up the blood progenitors by Piezo.

Kapoor A, Kumar A, Mukherjee T Proc Natl Acad Sci U S A. 2023; 120(23):e2306004120.

PMID: 37228115 PMC: 10265945. DOI: 10.1073/pnas.2306004120.


De Novo Generation of Human Hematopoietic Stem Cells from Pluripotent Stem Cells for Cellular Therapy.

Ding J, Li Y, Larochelle A Cells. 2023; 12(2).

PMID: 36672255 PMC: 9857267. DOI: 10.3390/cells12020321.


Lessons from early life: understanding development to expand stem cells and treat cancers.

Bain F, Che J, Jassinskaja M, Kent D Development. 2022; 149(20).

PMID: 36217963 PMC: 9724165. DOI: 10.1242/dev.201070.


Recent Advances in Developmental Hematopoiesis: Diving Deeper With New Technologies.

Weijts B, Yvernogeau L, Robin C Front Immunol. 2021; 12:790379.

PMID: 34899758 PMC: 8652083. DOI: 10.3389/fimmu.2021.790379.

References
1.
Kissa K, Herbomel P . Blood stem cells emerge from aortic endothelium by a novel type of cell transition. Nature. 2010; 464(7285):112-5. DOI: 10.1038/nature08761. View

2.
Kina T, Ikuta K, Takayama E, Wada K, Majumdar A, Weissman I . The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol. 2000; 109(2):280-7. DOI: 10.1046/j.1365-2141.2000.02037.x. View

3.
Diebold L, Chandel N . HSC Fate Is Tethered to Mitochondria. Cell Stem Cell. 2016; 18(3):303-4. DOI: 10.1016/j.stem.2016.02.007. View

4.
Perry J, He X, Sugimura R, Grindley J, Haug J, Ding S . Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Genes Dev. 2011; 25(18):1928-42. PMC: 3185965. DOI: 10.1101/gad.17421911. View

5.
Hoggatt J, Mohammad K, Singh P, Pelus L . Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness. Blood. 2013; 122(17):2997-3000. PMC: 3811174. DOI: 10.1182/blood-2013-07-515288. View